Cargando…
Pyrazinamide Susceptibility Is Driven by Activation of the SigE-Dependent Cell Envelope Stress Response in Mycobacterium tuberculosis
Pyrazinamide (PZA) plays a crucial role in first-line tuberculosis drug therapy. Unlike other antimicrobial agents, PZA is active against Mycobacterium tuberculosis only at low pH. The basis for this conditional drug susceptibility remains undefined. In this study, we utilized a genome-wide approach...
Autores principales: | Thiede, Joshua M., Dillon, Nicholas A., Howe, Michael D., Aflakpui, Ranee, Modlin, Samuel J., Hoffner, Sven E., Valafar, Faramarz, Minato, Yusuke, Baughn, Anthony D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805019/ https://www.ncbi.nlm.nih.gov/pubmed/35100871 http://dx.doi.org/10.1128/mbio.00439-21 |
Ejemplares similares
-
Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis
por: Modlin, Samuel J., et al.
Publicado: (2021) -
Pyrazinamide-resistant Tuberculosis Obscured From Common Targeted Molecular Diagnostics
por: Modlin, Samuel J., et al.
Publicado: (2023) -
SigE: A master regulator of Mycobacterium tuberculosis
por: Manganelli, Riccardo, et al.
Publicado: (2023) -
Detection of Pyrazinamide Heteroresistance in Mycobacterium tuberculosis
por: Werngren, Jim, et al.
Publicado: (2021) -
Overlapping SigH and SigE sigma factor regulons in Corynebacterium glutamicum
por: Busche, Tobias, et al.
Publicado: (2023)